Detection of a codon 515 or p.S505N variant is clinically significant for supporting a diagnosis of ET or PMF in the presence of specific symptoms and clinical features in conjunction with the absence of JAK2 p.V617F. The gene discussed is JAK2; the disease is essential thrombocythemia.